Uckert W, Willimsky G, Pedersen F S, Blankenstein T, Pedersen L
Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
Hum Gene Ther. 1998 Nov 20;9(17):2619-27. doi: 10.1089/hum.1998.9.17-2619.
The gibbon ape leukemia virus (GaLV) and the amphotropic murine leukemia virus (A-MuLV) infect human cells via specific receptors, Pit1 and Pit2, respectively. mRNA levels of these receptors were determined by Northern analysis and for Pit2 in addition by quantitative RT-PCR. Pit1 and Pit2 were expressed in different amounts in human tissues and cell lines; Pit1-specific mRNA was generally more abundant than Pit2 mRNA. No correlation was found between Pit1 and Pit2 RNA levels and infectibility by GaLV and A-MuLV pseudotyped vectors, respectively. GaLV and A-MuLV revealed a partial reciprocal interference. MuLV-10A1 can utilize both Pit1 and Pit2 for entry into cells but could not infect any of the 14 human cell lines more efficiently than A-MuLV or GaLV. Interference assays suggested that MuLV-10A1 has a higher affinity for and infected most cells predominantly by Pit2. However, at least in one cell line it used Pit1 more efficiently for entry. We conclude that (1) Pit1 and Pit2 mRNA levels in human cells are not indicative of the infectibility by GaLV and A-MuLV pseudotypes, respectively; (2) A-MuLV can infect target cells as efficiently as can GaLV, although Pit2 RNA is less abundant than Pit1 RNA; (3) factor(s) in addition to the presence of Pit1 and Pit2 are involved in retroviral infection; and (4) MuLV-10A1 pseudotype does not infect human cells more efficiently than do A-MuLV and GaLV pseudotypes.
长臂猿白血病病毒(GaLV)和嗜双性鼠白血病病毒(A-MuLV)分别通过特定受体Pit1和Pit2感染人类细胞。通过Northern分析确定这些受体的mRNA水平,对于Pit2还通过定量逆转录PCR进行测定。Pit1和Pit2在人类组织和细胞系中的表达量不同;Pit1特异性mRNA通常比Pit2 mRNA更丰富。分别未发现Pit1和Pit2的RNA水平与GaLV和A-MuLV假型载体的感染性之间存在相关性。GaLV和A-MuLV显示出部分相互干扰。MuLV-10A1可以利用Pit1和Pit2进入细胞,但在14种人类细胞系中,其感染效率均不比A-MuLV或GaLV更高。干扰试验表明,MuLV-10A1对Pit2具有更高的亲和力,并且主要通过Pit2感染大多数细胞。然而,至少在一种细胞系中,它更有效地利用Pit1进入细胞。我们得出以下结论:(1)人类细胞中Pit1和Pit2的mRNA水平分别不表明对GaLV和A-MuLV假型的感染性;(2)尽管Pit2 RNA比Pit1 RNA含量少,但A-MuLV感染靶细胞的效率与GaLV相同;(3)除了Pit1和Pit2的存在外,还有其他因素参与逆转录病毒感染;(4)MuLV-10A1假型感染人类细胞的效率不比A-MuLV和GaLV假型更高。